|
|
Title | Creator | Date |
101 |
|
Ocular Myasthenia Gravis Associated With Thymic Amyloidosis | Kristin O. Chapman, MD; Debra M. Beneck, MD; Marc J. Dinkin, MD | 2016-03 |
102 |
|
Optic Neuropathy Due to Chronic Lymphocytic Leukemia Proven With Optic Nerve Sheath Biopsy | Khurrum Khan, BS; Amina I. Malik, MD; Sumayya J. Almarzouqi, MD; Michael L. Morgan, MD; Sushma Yalamanchili, MD; Patricia Chevez-Barrios, MD; Andrew G. Lee, MD | 2016-03 |
103 |
|
Optic Nerve Sheath Melanoma Presenting as a Central Retinal Vein Occlusion | Alexander Barash, MD; Patrick A. Sibony, MD; Nigel A. Stippa, BS; Nariman S. Boyle, MD; James E. Davis, MD | 2016-03 |
104 |
|
Homonymous Hemianopic Hyporeflective Retinal Abnormality on Infrared Confocal Scanning Laser Photography: A Novel Sign of Optic Tract Lesion | Mario L. R. Monteiro, MD, PhD; Rafael B. Araújo, MD; Ana C. F. Suzuki, MD; Leonardo P. Cunha, MD, PhD; Rony C. Preti, MD, PhD | 2016-03 |
105 |
|
Development of Dural Arteriovenous Fistulas After Cerebral Venous Sinus Thrombosis | Jonathan A. Micieli, MD, CM; Sheldon Derkatch, MD; Vitor M. Pereira, MD; Edward A. Margolin, MD | 2016-03 |
106 |
|
Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial | Martin W. ten Hove, MD; Deborah I. Friedman, MD; Anil D. Patel, MD; Isabella Irrcher, PhD; Michael Wall, MD; Michael P. McDermott, PhD; for the NORDIC Idiopathic Intracranial Hypertension Study Group | 2016-03 |
107 |
|
Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial | Kimberly E. Cello, BS; John L. Keltner, MD; Chris A. Johnson, PhD; Michael Wall, MD for the NORDIC Idiopathic Intracranial Hypertension Study Group | 2016-03 |
108 |
|
Chronic Myelogenous Leukemia Relapse Presenting With Central Nervous System Blast Crisis and Bilateral Optic Nerve Infiltration | Joyce N. Mbekeani, MD, FRCS, FRCOphth; Maaly Abdel Fattah, MD, PhD; Randa M. Al Nounou, MD; Wahiba Chebbo, MD; Mohammed Asif Dogar, MD | 2016-03 |
109 |
|
Lambert-Eaton Myasthenic Syndrome: Ocular Signs and Symptoms | Jeffery D. Young, MD; Jacqueline A. Leavitt, MD | 2016-03 |
110 |
|
Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis | Sean M. Gratton, MD; Angela M. Herro, MD; William J. Feuer, MS; Byron L. Lam, MD | 2016-03 |
111 |
|
Relationship Between Age, Gender, and Race in Patients Presenting With Myasthenia Gravis With Only Ocular Manifestations | Jason H. Peragallo, MD; Elena Bitrian, MD; Mark J. Kupersmith, MD; Fritz Zimprich, MD, PhD; Thomas J. Whittaker, MD, JD; Michael S. Lee, MD; Beau B. Bruce, MD, PhD | 2016-03 |
112 |
|
Peripapillary Retinal Nerve Fiber Layer Thickness Corresponds to Drusen Location and Extent of Visual Field Defects in Superficial and Buried Optic Disc Drusen | Lasse Malmqvist, MD; Marianne Wegener, MD; Birgit A. Sander, MSc, PhD; Steffen Hamann, MD, PhD | 2016-03 |
113 |
|
The Idiopathic Intracranial Hypertension Treatment Trial: A Long-Time Coming but Worth the Wait | Roy W. Beck, MD, PhD | 2016-03 |
114 |
|
Innocent Until Proven Guilty | Heather E. Moss, MD, PhD; Tiffani S. Stroup, DO; Amy Y. Lin, MD; Oliver W. Graf, MD; Aaron M. Halfpenny, DO; Howard L. Lipton, MD; Ari M. Blitz, MD; Tibor Valyi-Nagy, MD, PhD | 2016-03 |
115 |
|
Literature Commentary | Mark L. Moster, MD; M. Tariq Bhatti, MD | 2016-03 |
116 |
|
Neuro-Ophthalmology of Space Flight | Andrew G. Lee, MD; William J. Tarver, MD; Thomas H. Mader, MD, Col (R); Charles Robert Gibson, OD; Stephen F. Hart, MD; Christian A. Otto, MD, MMSc | 2016-03 |
117 |
|
Neuro-Ophthalmic Syndromes and Processing Speed in Multiple Sclerosis | Silvana L. Costa, PhD; Óscar F. Gonçalves, PhD; Nancy D. Chiaravalloti, PhD; John DeLuca, PhD; Jorge Almeida, PhD | 2016-03 |
118 |
|
Asymmetric Papilledema in Idiopathic Intracranial Hypertension: Comment | Thomas H. Mader, MD; C. Robert Gibson, OD; Stephen F. Hart, MD | 2016-03 |
119 |
|
Bariatric Surgery and the Neuro-Ophthalmologist | Heather E. Moss, MD, PhD | 2016-03 |
120 |
|
Books Received: Handbook of Neuroimaging for the Ophthalmologist | Michael S. Vaphiades, MD | 2016-03 |
121 |
|
Cilioretinal Artery Territory Infarction Associated With Papilledema in a Patient With Neurofibromatosis Type 2 | Omar A. Mahroo, PhD, FRCOphth; Moin D. Mohamed, PhD, FRCOphth; Elizabeth M. Graham, FRCOphth; Samantha S. Mann, MD, FRCOphth; Gordon T. Plant, MD, FRCP; Shazia K. Afridi, MRCP, PhD; Christopher J. Hammond, MD, FRCOphth | 2016-03 |
122 |
|
Delayed Development of Intracranial Hypertension After Discontinuation of Tetracycline Treatment for Acne Vulgaris | Christine Law, MD; Gary L. Yau, MD; Martin ten Hove, MEng, MD, FRCSC | 2016-03 |